Liquidia CORP Form 4 insider transactions
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, sold 8,283 shares of common stock on April 14, 2025, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling shares to cover taxes associated with the vesting of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, reports the vesting and sale of common stock to cover taxes, alongside ongoing holdings of restricted stock units.
NASDAQ
LQDA
Liquidia CORPChief Business Officer Jason Adair reports stock transactions, including the vesting and sale of restricted stock units, under a pre-arranged trading plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's General Counsel, Russell Schundler, reports the vesting and sale of restricted stock units (RSUs) and a sale of common stock to cover taxes.
NASDAQ
LQDA
Liquidia CORPChief Commercial Officer Scott Moomaw reports stock transactions including RSU vesting and sales to cover taxes.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, reports the vesting and sale of restricted stock units (RSUs) and stock sales under a 10b5-1 plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, sold 445 shares of common stock to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling shares to cover taxes associated with the vesting of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's General Counsel, Russell Schundler, reports the acquisition of stock units and the sale of shares to cover taxes.
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, reports acquisition of performance stock units and sale of common stock to cover taxes.
NASDAQ
LQDA
Liquidia CORPChief Commercial Officer Scott Moomaw reports acquisition of performance stock units and sale of common stock to cover taxes.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, reports acquisition and disposal of company stock and performance stock units.
NASDAQ
LQDA
Liquidia CORPChief Business Officer Jason Adair reports acquisition and disposal of Liquidia Corp stock, including vesting of restricted stock units and performance stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CEO, Roger Jeffs, reports acquisition and disposal of common stock, along with a grant of performance stock units (PSUs).
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Commercial Officer, Scott Moomaw, reports the vesting of restricted stock units and subsequent sale of shares to cover taxes.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, reports the vesting of restricted stock units and subsequent sale of shares to cover taxes.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's General Counsel, Russell Schundler, reports the acquisition of shares through vesting of restricted stock units and the sale of shares to cover taxes.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, reports the vesting of restricted stock units and subsequent sale of shares to cover taxes.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, sold 459 shares of common stock at $11.3081 per share under a pre-arranged 10b5-1 trading plan.
NASDAQ
LQDA
Liquidia CORPJason Adair, Chief Business Officer of Liquidia Corp, sold 459 shares of common stock on October 28, 2024, to cover taxes associated with the settlement of RSUs.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Medical Officer, Rajeev Saggar, sold shares of common stock to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPRussell Schundler, General Counsel of Liquidia Corp, sold 2,576 shares of common stock on October 14, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Medical Officer, Rajeev Saggar, sold shares of common stock to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPScott Moomaw, Chief Commercial Officer of Liquidia Corp, sold 1,527 shares of common stock on October 14, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, sold 3,892 shares of common stock on October 14, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp CEO Roger Jeffs sold 8,053 shares of common stock on October 14, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, reports the vesting and sale of restricted stock units (RSUs) and stock sales to cover taxes.
NASDAQ
LQDA
Liquidia CORPDirector Paul B. Manning reports acquiring shares in Liquidia Corp through a public offering and discloses beneficial ownership through various entities.
NASDAQ
LQDA
Liquidia CORPCaligan Partners LP reports acquiring additional shares of Liquidia Corp, increasing their total holdings.